CORNERSTONE THERAPEUTICS INC - FORM 8-K/A - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - March 16, 2012

Attached files

file filename
8-K/A - FORM 8-K AMENDMENT - CORNERSTONE THERAPEUTICS INCd315516d8ka.htm
EX-99.1 - AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF CARDIOKINE, INC. FOR 2008 AND 2009 - CORNERSTONE THERAPEUTICS INCd315516dex991.htm
EX-99.2 - AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF CARDIOKINE, INC. FOR 2009 AND 2010 - CORNERSTONE THERAPEUTICS INCd315516dex992.htm
EX-99.3 - UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS OF CARDIOKINE, INC. - CORNERSTONE THERAPEUTICS INCd315516dex993.htm
EX-99.4 - UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS OF THE COMPANY - CORNERSTONE THERAPEUTICS INCd315516dex994.htm

Exhibit 23.1

Consent of Independent Auditors

We consent to the incorporation by reference in the following Registration Statements:

 

  (1) Registration Statement (Form S-3 No. 333-166770) of Cornerstone Therapeutics Inc. and

 

  (2) Registration Statements (Form S-8 Nos. 333-119409, 333-125892, 333-131037, 333-133867, 333-156293, 333-161326, and 333-168542) of Cornerstone Therapeutics Inc.

of our reports dated May 12, 2011 and February 5, 2010, with respect to the consolidated financial statements of Cardiokine, Inc. for the years ended December 31, 2010, 2009, and 2008 included in this Current Report (Form 8-K/A) of Cornerstone Therapeutics Inc.

/s/ Ernst and Young LLP

Philadelphia, Pennsylvania

March 16, 2012

Stock widget

Investing forum

CORNERSTONE THERAPEUTICS INC Reports

Also read